Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Mary Sehl, M.D., Ph.D.
Mary Sehl, M.D., Ph.D.

Specialty:

Medical Oncology

General Information:

Gender:
Female
Language(s):
English

Affiliation(s):

Clinical Instructor, Department of Medicine, Hematology/Oncology
Member, JCCC Patients and Survivors Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica

Education:

Fellowship:
Hematology-Oncology, UCLA School of Medicine, 2005 - 2009
Geriatric Medicine, UCLA School of Medicine, 2004 - 2005
Residency:
Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, 2002 - 2004
Internship:
Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, 2001 - 2002
Medical Degree:
M.D., Brown University School of Medicine, 2001
Degree:
Ph.D., Biomathematics, UCLA, 2009

Certification(s):

Medical Board Certification(s):
Geriatric Medicine, American Board of Internal Medicine, 2008
Internal Medicine, American Board of Internal Medicine, 2004

Contact Information:

Phone:
(310) 560-5876
Email:

Practice Information:

Clinical Interest(s):
Breast cancer
Geriatric oncology

Scientific Interest(s):

Dr. Mary Sehl is interested in mathematical and statistical modeling in translational cancer research. One focus is in aging and cancer, with work studying patterns and predictors of functional decline in older breast cancer survivors. Another interest is in stochastic modeling of cancer stem cell extinction and niche dynamics that can be applied to leukemias as well as solid tumors. Other projects involve implementing statistical methods to best analyze cumulative genetic effects and gene-gene interactions in patients at high risk for breast cancer.

Selected Cancer-Related Publications:

Zhou H, Sehl ME, Sinsheimer JS, Lange K. Association screening of common and rare genetic variants by penalized regression. Bioinformatics. 2010 Oct 1;26(19):2375-82.

Sehl ME, Sinsheimer JS, Zhou H, Lange KL. Differential destruction of stem cells: implications for targeted cancer stem cell therapy. Cancer Res. 2009 Dec 15;69(24):9481-9.

Sehl ME, Langer LR, Papp JC, Kwan L, Seldon JL, Arellano G, Reiss J, Reed EF, Dandekar S, Korin Y, Sinsheimer JS, Zhang ZF, Ganz PA. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. Clin Cancer Res. 2009 Mar 15;15(6):2192-203.

Sehl ME, Satariano WA, Ragland DR, Reuben DB, Naeim A. Attribution of functional limitation to cancer decreases in the year following breast cancer diagnosis in older patients. Crit Rev Oncol Hematol. 2009 Jul;71(1):62-9.

Crandall CJ, Sehl ME, Crawford SL, Gold EB, Habel LA, Butler LM, Sowers MR, Greendale GA, Sinsheimer JS. Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women. Breast Cancer Res. 2009;11(4):R51.